Kirk E. Evoy is a Clinical Assistant Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Assistant Professor in the School of Medicine at the University of Texas Health Science Center at San Antonio. In addition to his teaching and research responsibilities within the college, Dr. Evoy also cares for patients as an ambulatory pharmacist within the University Health System in San Antonio.  Dr. Evoy completed his Pre-pharmacy and Doctor of Pharmacy coursework at Purdue University. Upon completion of pharmacy school, he went on to complete a PGY1 Pharmacy Practice Residency at the University of Wisconsin Hospital and Clinics in Madison, Wisconsin followed by a PGY2 Ambulatory Care Residency at Saint Joseph Regional Medical Center in Mishawaka, Indiana. In addition to his residency training, Dr. Evoy completed two teaching certificate programs and a Certificate of Added Training in Global Health, and has earned Board Certification as an Ambulatory Care Pharmacist (BCACP), Advanced Diabetes Manager (BC-ADM), and Tobacco Treatment Specialist (CTTS).  Dr. Evoy’s primary areas of research include substance use disorders and smoking cessation.  His clinical interests include primary care, particularly diabetes management, smoking cessation, and transitions of care, as well as global health.

Disclosure: Dr. Evoy has no financial relationship(s) to disclose.

Luke Smedley is a clinical pharmacy specialist in the medical and cardiothoracic intensive care units at University Health in San Antonio, Texas. After growing up in Indianapolis, Indiana and graduating from the Purdue University College of Pharmacy in 2017, he completed a PGY1 and PGY2 Critical Care pharmacy residency at University Health. After residency, he worked as a critical care and emergency medicine clinical pharmacist at Nebraska Medicine in Omaha, Nebraska before relocating back to San Antonio in mid-2020. In his current role, he precepts students and residents on a unique evening critical care rotation experience, as well as precepting Pharmacotherapy Rounds, Pharmacotherapy Seminar, and drug use evaluations for the PGY1 and PGY2 residency programs. His clinical interests include hemodynamic evaluation and shock management, pharmacokinetic/pharmacodynamic alterations in critically ill patients, and critical care endocrinology.

Dr. Kubes was born and raised in Houston, Texas. She graduated from Texas A&M University in 2006 with a BS in Biomedical Sciences, then attended the University of Houston College of Pharmacy and graduated in 2011. Dr. Kubes continued her post graduate education as a PGY1 resident at Memorial Hermann Hospital in the Houston Medical Center and then a PGY2 pediatrics residency at Children’s Memorial Hermann Hospital. Following residency, she accepted a position as a Pediatric Critical Care Clinical Specialist at Cincinnati Children’s Hospital. In 2014, she re-located to San Antonio and took on the role as the Pediatric Infectious Diseases and Antimicrobial Stewardship Pharmacist at The Children’s Hospital of San Antonio. Dr. Kubes joined the UT group in 2018 as a Clinical Assistant Professor in the Pharmacotherapy Division of the College of Pharmacy at The University of Texas at Austin, as well as an Adjoint Assistant Professor in the School of Medicine and The Department of Pediatrics at the University of Texas Health Science Center at San Antonio. In addition to her teaching and research responsibilities within the college, Dr. Kubes is also responsible for clinical pharmacy services and caring for pediatric patients within the University Health System in San Antonio. Dr. Kubes also sits on the CTSHP board as a senior board member, has been appointed by the Texas Attorney General’s office and the Texas Health and Human Services commission as a Texas Medicaid Drug Utilization Review Board Member, serves as the Chair for the UT affiliated Residency Programs and vice chair for the general pediatrics special interest group for the Pediatric Pharmacy Association national organization. Her primary areas of research include quality improvement in pediatrics, cystic fibrosis and infectious diseases. Her clinical interests include pediatrics, infectious diseases and maternal health. In her spare time she is a mom to 3 children, an avid gardener, baker, reader and chicken/turkey/pheasant/duck/quail/bunny/piggy tender.

Dusten is a Network Clinical Pharmacy Specialist in Infectious Diseases at Dell Seton Medical Center at The University of Texas and the PGY2 Infectious Diseases Residency Program Director in Austin. He attended Michigan State University to complete pre-pharmacy requirements and received his Doctor of Pharmacy from Ferris State University. He completed his PGY1 at St. Mary’s Health in Michigan and specialty training in infectious diseases from UC Davis Medical Center in Sacramento. Following residency, he moved back to the Midwest where he worked as the Infectious Diseases Clinical Pharmacist at Indiana University Health. His clinical responsibilities were divided between rounding on the infectious diseases consultation service, maintaining an outpatient practice for HIV patients in the Indianapolis area, and working on several antimicrobial stewardship initiatives. He moved to Austin in 2014 focusing on inpatient antimicrobial stewardship, pharmacist and physician education, and the development of guidelines. He enjoys teaching UT College of Pharmacy students as an assistant professor of practice in the Infectious Diseases modules and precepting PGY1 and PGY2 pharmacy residents. Additional areas of interest include: HIV, ID in immunocompromised patients, and antimicrobial resistance.

• Discuss the basic pharmacology of the new drugs presented and how the pharmacologic actions related to both therapeutic and adverse  effects

• Cite recent changes in pharmacy law and rule and their impact on daily hospital pharmacy practice
• Discuss impact of the COVID-19 pandemic on pharmacy practice rules and procedures

Dr. Tucker serves at the Executive Director and Secretary of the Texas State Board of Pharmacy (TSBP).  Dr. Tucker comes to TSBP with decades of experience as a pharmacist in multiple pharmacy settings and with a long history of service to the practice of pharmacy.  Dr. Tucker served a six-year term on the Tennessee Board of Pharmacy and has held membership and leadership positions across multiple pharmacy-related organizations, including the American Pharmacists Association, the Tennessee Pharmacists Association, the National Association of Boards of Pharmacy, the Society of Independent Pharmacists, and many more. He also served on the Accreditation Council for Pharmacy Education for over seven years. Dr. Tucker received a Doctor of Pharmacy degree from the University of Tennessee in 1988 and a Bachelor of Science degree in Chemistry from Union University in 2002

• Design parenteral nutrition (PN) regimens in patients with various nutritional needs.
• Identify common PN-related errors with a focus on the PN use process.
• Review available ASPEN recommendations and resources for safe PN use.
• Discuss action items to promote and implement PN safety recommendations

Todd W. Canada, Pharm.D., BCNSP, BCCCP, FASHP, FTSHP, FASPEN serves as a clinical pharmacy services manager and nutrition support team coordinator for the University of Texas MD Anderson Cancer Center in Houston, Texas.  He received his B.S. in Pharmacy from the University of Oklahoma Health Sciences Center and his post-baccalaureate Pharm.D. from the University of Texas Health Science Center at San Antonio.  He completed a specialized residency in Critical Care / Nutrition Support at the University of Tennessee-Memphis and has been board certified in nutrition support since 1996 and critical care since 2016. His current responsibilities include providing direct patient care, managing and mentoring his group of 12 non-oncology clinical pharmacy specialists, and serving as a pharmacy educator and preceptor.  Todd’s professional experience includes a variety of direct patient care, teaching, and research activities focusing on the critically ill in several large health-systems and academic centers in Dallas, San Antonio and Houston over the past 34 years. Todd currently serves on the Board of Pharmacy Specialties – Nutrition Support Specialty Council and previously served on the American Society for Parenteral and Enteral Nutrition Board of Directors.  He has presented and published in a variety of areas including safe practices for parenteral nutrition, critical care pharmacy practice and pharmacy mentoring/precepting.

Disclosure: Dr. Canada has no financial relationship(s) to disclose.

• Discuss common communication difficulties between preceptor and student as well as between pharmacy staff
• Describe best practices in difficult conversations and critical feedback

• Review select drug calculations
• Calculate medication doses and volumes given medication orders
• Illustrate calculation errors associated with said medication orders
• Discuss methods to prevent and/or catch calculation errors

• Discuss proposed revisions to USP <797>
• Compare and contrast USP <797> 2008, 2019, and 2021

• Describe the current state of the opioid overdose epidemic
• Identify pain stewardship strategies that pharmacists can use to improve the quality of care that patients receive for both pain and substance use disorder.
• Articulate how you as a practitioner can incorporate these strategies into your practice/heath system as a hospital pharmacist.  

• Identify the types of trauma and the prevalence of trauma in the general population
• Describe how trauma impacts individuals physiologically, psychologically, and emotionally
• Recognize trauma response and indicators in patients, co-workers. And students in the healthcare setting
• Demonstrate trauma-informed practice responses, reporting, and adaptions for accommodating trauma and trauma response
• This activity may be counted as one hour of CPE for preceptor credit

• Describe drugs involved in diversion and the impact on the opioid crisis
• Discuss how to identify potential prescribing and diversion red flags and action steps regarding suspicious activities

• Discuss how preventative suicide screening models can be used to identify at-risk individuals and establish care plans that reduce suicide while allocating resources effectively.
• Utilize a systemic best-practice measurement, the C-SSRS, to identify suicidal ideation and behavior to improve risk identification and safety monitoring.
• Demonstrate how the C-SSRS enables more streamlined triage, provides liability protection and facilitates care delivery to those at highest risk.

• Discuss often used complementary and alternative medicines (CAM) often used in psychiatric treatments
• Review evidence to evaluate agents that may be beneficial vs no benefit
• Discuss potential ethical issues related to use of CAM in psychiatric treatments

Dr. Toups is a clinician scientist specializing in the study of the interplay between physical and mental functions in health and disease. Her work focuses on understanding the effects of medical illness, particularly chronic inflammatory disorders, on mood and function. She completed a clinical research fellowship at the Center for Depression Research and Clinical Care at UT Southwestern in Dallas, TX and is an expert in the management of treatment resistant depression with a special interest in patients with co-morbid autoimmune and metabolic disorders. She also has extensive experience in clinical trials developing new ways of assessing and treating depression. Dr. Toups’ current research focuses on understanding specific mechanisms of bi-directional communication between the brain and immune system. Imbalance in this communication increases the risk of depression, as well as chronic inflammatory disorders such as diabetes. Dr. Toups is using genomic, gene expression, and metabolic analyses to better understand why some people are more vulnerable to this maladaptive pattern of brain-immune function with the ultimate goal of identifying targets for future therapies.